REGN vs SO · P/E 14, rev $14.34B vs P/E 22, rev $29.55B
Regeneron Pharmaceuticals Inc (REGN) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the REGN and SO stock pages for the full models.
Not investment advice.